New fatty liver drug begins first human tests
NCT ID NCT07407634
Summary
This early-stage study aims to test the safety and basic effects of a new drug called XTYW007 in healthy adults and people with high 'bad' cholesterol. Researchers will give single and multiple doses to about 94 participants to see how the body processes the drug and if it affects blood fat levels. The main goal is to understand if the drug is safe and well-tolerated before testing it for treating fatty liver disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Hospital of Jilin University
Jilin, Changchun, China
Conditions
Explore the condition pages connected to this study.